Vega Iranzo

756 citations
46 papers · 467 indexed · h-index 14
Topics
Pancreatic and Hepatic Oncology Research (10 papers)Renal cell carcinoma treatment (5 papers)Cancer Genomics and Diagnostics (5 papers)
Partner nations
SpainItalyBelgium

In The Last Decade

Vega Iranzo

44 papers receiving 462 citations

Peers

Vega Iranzo
Comparison fields: 5 of 64
  • Oncology 294
  • Pulmonary and Respiratory Medicine 198
  • Cancer Research 117
  • Molecular Biology 111
  • Epidemiology 71
Replace Masato Matsuyama with:
Masato Matsuyama Japan
A.R. Abdul Razak Canada
Motohiko Tokuhisa Japan
James P. De Andrade United States
Eihab Abdelfatah United States
James Hu United States
Yingbo Chen China
Hyungwoo Cho South Korea
S. Della Torre Italy
Hidekazu Hirano Japan
Vega Iranzo relative to Masato Matsuyama Japan Masato Matsuyama's profile →
Citations per field
00.5×
Masato Matsuyama · 1×
Citations per year

Countries citing papers authored by Vega Iranzo

Since Specialization
Citations

This map shows the geographic impact of Vega Iranzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vega Iranzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vega Iranzo more than expected).

Fields of papers citing papers by Vega Iranzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vega Iranzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vega Iranzo. The network helps show where Vega Iranzo may publish in the future.

Co-authorship network of co-authors of Vega Iranzo

This figure shows the co-authorship network connecting the top 25 collaborators of Vega Iranzo. A scholar is included among the top collaborators of Vega Iranzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vega Iranzo. Vega Iranzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 3
3 4
4 43
5 8
6 5
7 3
8 2
9 0
10 15
11 1
12 1
13 4
14 15
15 16
16 6
17 5
18 26
19 21
20 2

About Vega Iranzo

Vega Iranzo is a scholar working on Oncology, Geriatrics and Gerontology and Pulmonary and Respiratory Medicine, having authored 46 papers that have together received 467 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (10 papers), Renal cell carcinoma treatment (5 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Oncology (294 citations), Cancer Research (117 citations) and Pulmonary and Respiratory Medicine (198 citations). Vega Iranzo has collaborated with scholars based in Spain, Italy and Belgium. Frequent co-authors include Carlos Camps, Rafael Sirera, José Ángel García, Silvia Calabuig‐Fariñas, Susana Torres‐Martínez, Roy M. Bremnes, Ana Blasco, Miquel Tarón, Rafael Rosell and Marta Martín-Richard. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026